Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients. | Int J Nephrol Renovasc Dis;7: 261-9, 2014. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Nursing VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients.

Farrand, Kimberly F; Copley, J Brian; Heise, Jamie; Fridman, Moshe; Keith, Michael S; Poole, Lynne.

Affiliation

Farrand KF; Shire, Wayne, PA, USA.
Copley JB; Shire, Wayne, PA, USA.
Heise J; Shire, Wayne, PA, USA.
Fridman M; AMF Consulting, Los Angeles, CA, USA.
Keith MS; Shire, Wayne, PA, USA.
Poole L; Shire, Basingstoke, UK.

Int J Nephrol Renovasc Dis ; 7: 261-9, 2014.

Article in En | MEDLINE | ID: mdl-25045277

Key words

chronic kidney disease; end-stage renal disease; hyperphosphatemia

Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Int J Nephrol Renovasc Dis Year: 2014 Type: Article Affiliation country: United States

Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Int J Nephrol Renovasc Dis Year: 2014 Type: Article Affiliation country: United States